Fundamental Analysis — Beginner to Expert · Part 8 of 29
Capstone: reading one real company with the whole toolkit
Putting it together
By now this blog has covered how to read three financial statements, roughly twenty ratios, and the machinery of valuation. Each one arrived in isolation. That’s the wrong way to actually use them — nobody computes a debtor-days figure and stops.
So this post, the capstone to the first module of this series, does one pass over one real company, in the order you’d sensibly do it, showing how the pieces build on each other. The company is Britannia Industries, the anchor used throughout this blog, and every figure comes from its audited consolidated FY25 results (year ended 31 March 2025, filed with the NSE (National Stock Exchange) and BSE on 8 May 2025), with the share price being the NSE close on 30 June 2025. All of it historical, and used here purely to illustrate the method.
One thing this post does not do is arrive at a verdict on the stock. There’s a section at the end on why that’s a deliberate stopping point rather than a cop-out.
Step 1: what does the business actually do?
Before a single ratio. Britannia makes biscuits, bread, cakes, rusk and dairy products, sells them through a distribution network reaching millions of Indian retail outlets, and owns brands — Good Day, Marie Gold, NutriChoice, Milk Bikis — that people ask for by name.
That paragraph already tells you what to expect from the numbers: modest gross margins (food inputs are commodities), heavy advertising spend, fast inventory turns (biscuits have shelf lives), and pricing power that shows up in the margin line rather than in volumes. If the ratios contradicted that picture, the interesting question would be why.
Skipping this step is how people end up computing a current ratio for a bank and concluding something silly.
Step 2: profitability
| Ratio | Britannia FY25 | Desi Bites FY25 |
|---|---|---|
| Gross margin | 40.9% | 38.0% |
| EBITDA margin | 17.8% | 17.0% |
| Net margin | 12.1% | 8.1% |
| ROE | 52.5% | 34.0% |
| ROCE | 49.5% | 31.2% |
| ROA | 24.3% | 16.2% |
A 40.9% gross margin narrowing to a 12.1% net margin is the shape of a consumer-brands business: the gap is advertising, distribution and staff. Returns are high — a 49.5% ROCE means the business earns roughly half its capital employed back every year in operating profit.
Note the FY25 detail that a single year’s table hides. Revenue grew about 7% while EBITDA was almost flat, because input costs rose faster than prices — gross margin compressed year on year. Good years and bad years both need reading; this was a margin-pressure year for a business that usually doesn’t have them.
Step 3: why the returns are what they are
The DuPont decomposition turns the ROE from a score into an explanation:
| Component | Britannia | Desi Bites |
|---|---|---|
| Net margin | 12.14% | 8.06% |
| Asset turnover | 2.00x | 2.01x |
| Equity multiplier (avg basis) | 2.16x | 2.09x |
| ROE | 52.5% | 34.0% |
Turnover and leverage are near-identical across the two companies. Nearly all of the ROE gap is margin, which is consistent with brand and scale. That’s a specific, checkable claim about where the value in this business sits, and it points you at the right things to monitor: pricing power and input costs, not asset utilisation.
Step 4: efficiency and working capital
| Ratio | Britannia FY25 |
|---|---|
| Inventory days | 42.6 |
| Debtor days | 9.1 |
| Creditor days | 60.3 |
| Cash conversion cycle | −8.6 |
| Asset turnover | 2.0x |
That negative cash conversion cycle is the most interesting number in this entire post. Britannia collects from its customers in about 9.1 days while taking around 60.3 days to pay its own suppliers. Its suppliers are, in effect, financing its working capital.
That’s not an accounting trick — it’s what distribution power looks like in the accounts. Distributors pay quickly because they need the stock; suppliers accept long terms because the volume is worth having. Growth funds itself rather than consuming cash, which is why this business can grow without constantly raising money.
Step 5: is the balance sheet safe?
| Ratio | Britannia FY25 | Reads as |
|---|---|---|
| Current ratio | 1.08 | Thin on its face |
| Quick ratio | 0.74 | Below 1 |
| Debt-to-equity | 0.28 | Low |
| Interest coverage | 20.7x | Very comfortable |
| Net debt/EBITDA | -0.06x | Net cash |
Here’s where reading ratios in isolation would mislead you badly. A current ratio of 1.08 and a quick ratio of 0.74 look, by textbook rules of thumb, like a liquidity problem.
They aren’t, and the other rows explain why. Interest is covered 20.7 times over. Net debt is negative — the company holds more cash and liquid investments than total borrowings. And the negative cash conversion cycle from the previous step means large trade payables are a structural feature of how this business runs, not a sign of trouble paying bills. Those payables inflate current liabilities, which is exactly what drags the current ratio down.
The lesson generalises: a ratio that looks alarming in isolation often has its explanation two ratios away. Rules of thumb are a prompt to investigate, not a finding.
Step 6: is the profit real?
| Ratio | Britannia FY25 |
|---|---|
| Free cash flow | ₹2,105.8 Cr |
| OCF/PAT | 1.14x |
| Capex intensity | 2.1% |
An OCF/PAT ratio above 1 means reported profit is converting into actual cash — the single most useful check against accounting that flatters the income statement. Britannia’s 1.14x is healthy.
But apply the scepticism the FCF post built in. Free cash flow rose from FY24 to FY25 mainly because capex fell from 3.3% to 2.1% of revenue — operating cash flow actually declined slightly. A rising FCF driven by a capex pause is a different fact from a rising FCF driven by better operations, and only one of them is repeatable.
Step 7: what is the market paying?
At the 30 June 2025 closing price of ₹5,851:
| Multiple | Britannia |
|---|---|
| P/E | 64.7x |
| P/B | 32.4x |
| EV/EBITDA | 44.2x |
| Dividend yield | 1.26% |
| PEG | ~35.9 (on 1.8% FY25 PAT growth) |
Every one of these needs the context the earlier posts supplied. Take the P/B of 32.4x. P/B = P/E × ROE, so a business earning 52.5% on its book value mechanically produces a high P/B at any given P/E. Part of the reason ROE is that high is that the assets doing the work (brands, distribution relationships, shelf position) were built through the P&L over decades and appear nowhere on the balance sheet. That explains why the number is large; whether 32.4x is justified is exactly the question this post doesn’t answer.
The PEG of ~35.9 is the one to be most careful with, and the PEG post covered why: it divides a high P/E by a single weak year’s growth. That makes it unstable — a different base year would give a wildly different figure — so it tells you little either way here.
Step 8: what this exercise cannot tell you
The natural next step would be a discounted cash flow model, a value per share, and a comparison against the ₹5,851 price. This blog stops here, on purpose, and it’s worth being straight about why.
The compliance reason. Wealth Primer is educational. Publishing an intrinsic value for a specific listed stock is functionally a price target, and price targets are the work of SEBI-registered research analysts. That registration exists for good reasons and this blog doesn’t hold it. So the DCF machinery in this series was built on a fictional company, where the method can be shown in full without the output being mistaken for a call.
The intellectual reason, which matters more. Everything above is backward-looking. FY25 is history. The ratios describe a year that has already happened, and a valuation depends almost entirely on what happens next — which of these numbers persist, which mean-revert, which are about to be disrupted by something not in the accounts at all.
Financial statement analysis is superb at telling you what kind of business you’re looking at and which questions to ask next. It is close to silent on whether the price is right. The things it can’t see are exactly the things that usually decide the outcome:
- Management quality, capital allocation instincts, and integrity
- Competitive dynamics and whether the moat is widening or eroding
- Regulatory and input-cost shifts still ahead
- What the market has already priced in
The toolkit gets you to an informed question. It doesn’t get you to an answer, and any framework claiming otherwise is selling something.
How to actually run this on a company
Condensed to a checklist:
- Understand the business first. What it sells, to whom, and why they buy it. Then predict roughly what the ratios should look like.
- Read three years, not one. Trends carry more information than levels, and one year is mostly noise.
- Profitability, then efficiency, then leverage, then cash. In that order — each layer explains the previous one.
- Run DuPont on the ROE. It converts a score into a reason.
- Check profit converts to cash. OCF/PAT above 1, sustained.
- Never read a ratio alone. Britannia’s current ratio of 1.08 would have misled you completely without the four numbers around it.
- Compare against peers and against its own history, not against textbook thresholds.
- Write down what would change your mind. If nothing in the accounts could, you weren’t analysing — you were justifying.
Takeaway: No single ratio tells you anything; the toolkit works because each number explains the last one, and a figure that looks alarming alone usually has its answer two ratios away. Used well, financial statement analysis tells you what kind of business you’re looking at and which questions to ask next. It stops well short of telling you whether the price is right, and that limit is worth respecting.
This post is for educational purposes only and is not investment advice. Wealth Primer explains concepts, not recommendations — nothing here is a suggestion to buy, sell, or hold any specific security or fund. The author is not a SEBI-registered Research Analyst or Investment Adviser. Any prices or figures used as worked examples are historical and shown only to illustrate a calculation. Past performance does not indicate future results. Please do your own research or consult a registered adviser before making investment decisions. See the privacy & disclaimer policy for more.